Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2018

TORONTO, Oct. 26, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced its results for the fiscal year ended June 30, 2018.  The Audited Financial Statements and Management’s Discussion and Analysis for the year ended June 30, 2018, may be viewed on SEDAR at

Operational Activities Achieved in 2018